Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block Levels for Post-Cholecystectomy Analgesia
NCT04316416Completed
- Sponsor
- Gaziosmanpaşa Training and Research Hospital
- Start
- Feb 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine hydrochloride 0.75% injection and Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (3 arms), sponsored by Gaziosmanpaşa Training and Research Hospital. Primary endpoints: Postoperative pain change (Numeric Rating Scale) at 24 hours and Postoperative morphine consumption change at 24 hours. Started Feb 2020; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injectionLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04316416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04316416.